Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas.

Li, Shuang; Zou, Hecun; Shao, Ying-Ying; Mei, Ying; Cheng, Yu; Hu, Dong-Li; Tan, Zhi-Rong; Zhou, Hong-Hao

Li, Shuang; Zou, Hecun; Shao, Ying-Ying; Mei, Ying; Cheng, Yu; Hu, Dong-Li; Tan, Zhi-Rong; Zhou, Hong-Hao.

Afiliação

Li S; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China.
Zou H; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China.
Shao YY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China.
Mei Y; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Cheng Y; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China.
Hu DL; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China.
Tan ZR; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China.
Zhou HH; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China.

Oncotarget ; 8(63): 106962-106975, 2017 Dec 05.

Article em En | MEDLINE | ID: mdl-29291003

Palavras-chave

ANXA2; ANXA2P1 ANXA2P2 ANXA2P3; biomarkers; diffuse gliomas; pseudogene

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google